APW
SGMO

Atlantic Private Wealth’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Atlantic Private Wealth’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$247 Hold
1,000
– – ﹤0.01% 305
2025
Q4 		$420 Hold
1,000
– – ﹤0.01% 338
2025
Q3 		$673 Hold
1,000
– – ﹤0.01% 232
2025
Q2 		$541 Hold
1,000
– – ﹤0.01% 232
2025
Q1 		$656 Hold
1,000
– – ﹤0.01% 202
2024
Q4 		$1.02K Sell
1,000
-1,500
-60% -$2.74K ﹤0.01% 196
2024
Q3 		$2.17K Buy
+2,500
New +$1.83K ﹤0.01% 173

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Atlantic Private Wealth's SGMO Position: Q1 2026 in Review

Atlantic Private Wealth held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q1 2026 at 1,000 shares worth $247. The position accounts for ﹤0.01% of the portfolio, ranked #305.

Atlantic Private Wealth first reported a position in SGMO in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.17K in Q3 2024. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Atlantic Private Wealth held 1,000 shares of SANGAMO THERAPEUTICS INC worth $247 as of Q1 2026.
  • Atlantic Private Wealth left its SANGAMO THERAPEUTICS INC share count unchanged in Q1 2026.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Atlantic Private Wealth's portfolio in Q1 2026, its #305 holding.
  • Atlantic Private Wealth first reported a position in SANGAMO THERAPEUTICS INC in Q3 2024 and has held it in 7 quarters since.
  • Atlantic Private Wealth's SANGAMO THERAPEUTICS INC position peaked at $2.17K in Q3 2024.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Atlantic Private Wealth's 13F filing for Q1 2026, filed 8 May 2026.